...
首页> 外文期刊>Plant Biotechnology Journal >Engineered chloroplast dsRNA silences cytochrome p450 monooxygenase, V-ATPase and chitin synthase genes in the insect gut and disrupts Helicoverpa armigera larval development and pupation
【24h】

Engineered chloroplast dsRNA silences cytochrome p450 monooxygenase, V-ATPase and chitin synthase genes in the insect gut and disrupts Helicoverpa armigera larval development and pupation

机译:工程化叶绿体DsRNA沉默细胞色素P450单氧化酶,V- ATP酶和胰蛋白酶在昆虫肠道中扰乱Helicoverpa Armigera Larval发育和蛹化

获取原文
获取原文并翻译 | 示例
           

摘要

In the past two decades, chloroplast genetic engineering has been advanced to achieve high-level protein accumulation but not for down-regulation of targeted genes. Therefore, in this report, lepidopteran chitin synthase (Chi), cytochrome P450 monooxygenase (P450) and V-ATPase dsRNAs were expressed via the chloroplast genome to study RNA interference (RNAi) of target genes in intended hosts. PCR and Southern blot analysis confirmed homoplasmy and site-specific integration of transgene cassettes into the chloroplast genomes. Northern blots and real-time qRT-PCR confirmed abundant processed and unprocessed dsRNA transcripts (up to 3.45million copies of P450 dsRNAs/g total RNA); the abundance of cleaved dsRNA was greater than the endogenous psbA transcript. Feeding of leaves expressing P450, Chi and V-ATPase dsRNA decreased transcription of the targeted gene to almost undetectable levels in the insect midgut, likely after further processing of dsRNA in their gut. Consequently, the net weight of larvae, growth and pupation rates were significantly reduced by chloroplast-derived dsRNAs. Taken together, successful expression of dsRNAs via the chloroplast genome for the first time opens the door to study RNA interference/processing within plastids. Most importantly, dsRNA expressed in chloroplasts can be utilized for gene inactivation to confer desired agronomic traits or for various biomedical applications, including down-regulation of dysfunctional genes in cancer or autoimmune disorders, after oral delivery of dsRNA bioencapsulated within plant cells.
机译:在过去的二十年中,叶绿体基因工程已经前进以实现高水平的蛋白质积累,但不用于靶向基因的下调。因此,在本报告中,通过叶绿体基因组表达鳞翅目胰蛋白丁蛋白合成酶(CHI),细胞色素P450单氧化酶(P450)和V-ATP酶DSRNA,以研究预期宿主中的靶基因的RNA干扰(RNAi)。 PCR和Southern印迹分析证实了转基因盒在叶绿体基因组中的同型同源性和特异性集成。 Northern印迹和实时QRT-PCR确认丰富的加工和未加工的DSRNA转录物(高达3.45亿拷贝的P450DSRNA / G总RNA);裂解的dsRNA的丰度大于内源性PSBA转录物。表达P450,CHI和V-ATP酶DSRNA的饲喂叶片的转录减少了昆虫中肠的靶基因的转录,可能在其肠道进一步加工dsRNA后再处理DSRNA。因此,通过叶绿体衍生的DSRNA显着降低了幼虫,生长和灰化率的净重。连合在一起,第一时间通过叶绿体基因组成功表达DSRNAS开启门以研究塑性体内的RNA干扰/加工。最重要的是,在叶绿体中表达的DSRNA可用于基因失活以赋予所需的农艺性状或各种生物医学应用,包括在植物细胞中口服递送DSRNA生物胶囊后癌症或自身免疫障碍中的功能障碍基因的降调。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号